1-11501625-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020780.2(DISP3):c.633G>T(p.Glu211Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,608,354 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020780.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DISP3 | NM_020780.2 | c.633G>T | p.Glu211Asp | missense_variant | 2/21 | ENST00000294484.7 | NP_065831.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DISP3 | ENST00000294484.7 | c.633G>T | p.Glu211Asp | missense_variant | 2/21 | 1 | NM_020780.2 | ENSP00000294484.6 | ||
ENSG00000285833 | ENST00000649975.1 | n.392C>A | non_coding_transcript_exon_variant | 1/2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152248Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000466 AC: 11AN: 236304Hom.: 0 AF XY: 0.0000154 AC XY: 2AN XY: 129974
GnomAD4 exome AF: 0.0000158 AC: 23AN: 1456106Hom.: 0 Cov.: 36 AF XY: 0.00000691 AC XY: 5AN XY: 723848
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152248Hom.: 0 Cov.: 34 AF XY: 0.0000672 AC XY: 5AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2021 | The c.633G>T (p.E211D) alteration is located in exon 2 (coding exon 1) of the DISP3 gene. This alteration results from a G to T substitution at nucleotide position 633, causing the glutamic acid (E) at amino acid position 211 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at